ArticleBMC cancer2026

Efficacy and safety of anti-VEGF/VEGFR monotherapy and combination with immune checkpoint inhibitors for advanced or metastatic renal cell carcinoma: a network meta-analysis.

Min Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.